COURSE - INSTANT STREAMING ACCESS
.addeventatc { background-color:#49b40c!important; color:#ffffff!important; font-size:13px!important; padding:6px 20px 6px 12px!important; /* extra right padding for icon */ border-radius:6px!important; display:inline-flex!important; align-items:center!important; gap:6px!important; /* spacing between text and icon */ position:relative!important; } /* Icon fix */ .addeventatc .addeventatc_icon { position:absolute!important; right:10px!important; /* push icon to right edge */ width:12px!important; height:12px!important; background:url(https://cdn.addevent.com/libs/imgs/icon-calendar-fff-t1.svg) no-repeat center center!important; background-size:14px!important; }
Share:

Effective Genotoxic Impurities Assessment for Safer Drug Development and ICH-Compliant Risk Control

This course enables organizations to convert informal AI use into controlled, clearly defined processes that can be consistently explained, verified, and justified during inspections, reducing exposure created by undocumented practices and inconsistent personnel responses. This Course is designed for professionals responsible for result assessment, investigation oversight, and quality decisions that must withstand regulatory review.

REGISTER FOR THE COURSE

US $190 per learner

30-Days Unlimited Streaming Access

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }

REGISTER FOR THE COURSE

To Get 30-Day Access to ONLY this Course 

US $190 per learner
  • This course is Included in Subscription Pack
Subscription include access to entire Learning Library
/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
  • Study time : 60 Minutes
  • Skill Level: Intermediate
  • Course ID: TF3424
  • Assessment & Certification Included
  • Ask the Expert

Watch the Course Now  

Watch the Course Now   

About the Course

Genotoxic impurities remain a significant safety concern in pharmaceutical development because residual contaminants originating from synthesis, formulation processes, or product degradation may introduce mutagenic or genotoxic risk to patients. Regulatory expectations require these impurities to be identified, evaluated, controlled, and limited according to the stage of clinical development and eventual marketing requirements. Effective assessment approaches are therefore essential for maintaining product safety and supporting regulatory acceptance throughout development programs for small molecule drugs.


This course addresses the practical considerations involved in evaluating genotoxic impurities and understanding the toxicological principles that guide acceptable exposure limits. Particular attention is given to the distinction between genotoxicity and mutagenicity, the application of toxicological threshold concepts, and the role of Permitted Daily Allowance in impurity control strategies. The material also highlights the importance of coordinated cross-functional involvement when establishing impurity evaluation programs capable of supporting evolving development and regulatory expectations.

  • Strengthen Genotoxic Impurity Risk Evaluation Decisions:

    Participants will improve their ability to identify and evaluate impurities that may present genotoxic concern during pharmaceutical development. The course clarifies toxicological assessment principles used to determine acceptable exposure limits and impurity control priorities, helping teams support development decisions that remain aligned with ICH expectations as compounds advance through clinical and commercial stages.

  • Improve Cross-Functional Control of Impurity Assessment Programs:

    Effective impurity evaluation requires coordination across development, toxicology, formulation, and regulatory functions. This course clarifies the operational importance of toxicological threshold concepts, Permitted Daily Allowance determinations, and impurity risk communication so organizations can reduce uncertainty during development activities where incomplete assessments may create regulatory or patient safety exposure.

Key Areas Covered

  • Differences between genotoxicity and mutagenicity in pharmaceutical impurity evaluation
  • Safety concerns associated with residual impurities from synthesis, formulation, and degradation pathways
  • Risk-based assessment approaches for genotoxic impurities during drug development
  • Toxicological profile evaluation methods for impurity qualification and control decisions
  • Application of Toxicological Threshold of Concern (TTC) principles in impurity assessments
  • Use of Permitted Daily Allowance concepts to establish acceptable impurity exposure limits
  • ICH guideline expectations for controlling impurities during clinical development and commercialization
  • Cross-functional responsibilities supporting effective genotoxic impurity evaluation programs

Who Must Attend

  • Project Managers
  • Regulatory Affairs
  • Pharmaceutical Development
  • Scientists Toxicologists
  • Drug Discovery Scientists
  • CMC Scientists
  • Clinical Development Scientists

Quality training, expert insights, and answers that matter. Know your Expert

Dr. STEFANO PERSIANI

Dr. Stefano Persiani is Director of Translational Sciences and Pharmacokinetics at Rottapharm Biotech, Italy, with experience spanning pharmaceutical development, clinical pharmacology, and translational sciences. His background includes academic research positions in the United States and industry roles across drug development organizations. Dr. Persiani’s work from pre-clinical through Phase I and IIa development, together with his regulatory and scientific advisory activities, directly supports the evaluation and safety assessment principles discussed in this course.

If you would like to request a Proforma invoice to sign up for this course. please click here

Ready to Strengthen Your Team? Let’s Build Your Training Plan.

Whether you’re looking for a single onsite workshop or a multi-team training series, we’ll help you design a program that fits your goals, timelines, and operational reality.

Your team deserves the clarity.
Your organization deserves the confidence.

Upcoming Courses

Your TalkFDA Webinar Experience

When you reserve your seat, everything is organized for you — from access to certification from one place.

1. Confirmation
You receive a confirmation email and your course appears instantly in your TalkFDA dashboard.

2. Your Course Hub
Your TalkFDA course page becomes your central hub where you can watch the course, access materials, and manage your learning.

3. Access course materials
The presentation handout and other materials can be downloaded inside the Course Player. You could use Discussion feature there to ask your questions.

4. Watch The Streaming and Complete your Course
The course playback will be available on the same course page. You could pause and continue or you can revisit important sections.
5. Earn Your Certificate
Complete the course and your certificate is unlocked automatically in your learning history.

The challenge with training is rarely signing up. It’s what happens afterward, when access, materials, & certification aren’t accessible from one place.
With TalkFDA Courses, Everything you need Live in One Place.
Simple. Organized. Professional.
Go ahead and Take the Course with confidence.

Our students love us ❤️

“Content was put together well. Didn’t feel like random slides. One thing actually led to the next.”

Manager, Quality Assurance


“Pacing was right. Didn’t feel dragged. Didn’t feel rushed either.”

Senior Manager, Operations

“Structure helped. Otherwise this topic can get messy quickly.”



Validation Specialist, QA/IT

People who took this Course, also viewed